Institute for Molecular Medicine Finland, HiLIFE
Building a bridge from discovery to medicine
OUR MISSION: FIMM is a translational institute with a driving mission to perform innovative research on patients and populations - utilizing molecular, genomic and health data – targeted towards understanding drivers of health and disease and delivering improvements to the safety, efficacy and efficiency of healthcare in Finland and beyond.
Researchers in Finland and Norway have discovered a gene defect that causes a novel inherited immune deficiency. The same gene, DIAPH1, has been...
AI supported diagnostics can facilitate screening for cervical cancer in resource-poor settings
A new study from the University of Helsinki and Karolinska Institutet shows that artificial intelligence-supported digital microscopy at the...
Insights into how to better understand and treat COVID-19 are desperately needed. This page summarizes the FIMM efforts in contributing our researchers' expertise, technology and time to help to beat the COVID-19 pandemic.